Prescient Therapeutics Limited - Australian Company Profile

What does Prescient Therapeutics Limited do?

Prescient Therapeutics is a Public Company that generates the majority of its income from the Medical & Surgical Equipment Manufacturing industry.

In 2025 the company generated total revenue of $226,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Prescient Therapeutics is Mr Steven Yatomi-Clarke whose official title is CEO & Managing Director. The Chairman of Prescient Therapeutics is Mr Steve Engle whose official title is Non-Executive Chairman.

Thousands of companies, hundreds of industries

Get strategic insights and analysis on 700+ industries in Australia and thousands of companies with an annual membership.

Get in Touch

Prescient Therapeutics Limited is an ASX-listed company in the biotechnology industry. Operating in Australia, the company develops technology aimed at combatting a range of cancers using CAR-T and targeted therapy approaches, such as: CAR-T Therapy - for blood cancers, by taking immune cells from the patient's body that fight infection to train them outside the cells to recognize cancer cells. CellPryme - a platform for enhancing cell therapies by producing cells with superior phenotypes. OmniCAR - a universal immune receptor platform enabling T-cell activity and multi-antigen targeting with a single-cell product. PTX 200 - a novel PH domain inhibitor that inhibits an important tumor survival pathway to prevent the development of cancers. PTX 100 - a first-in-class compound with the ability to block an important cancer growth enzyme.

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Prescient Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Prescient Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Prescient Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Prescient Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Prescient Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Prescient Therapeutics Limited operates in.

Competitor Benchmarking

Compare Prescient Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Prescient Therapeutics Limited.

Subsidiaries

View a list of Prescient Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Prescient Therapeutics Limited, including founding information, past announcements, mergers and major projects.